Philip Palmieri
Infectious Disease · Albany, NYNPI 1376582411
Payments from drug & device makers
Across 722 payments — averaging $283.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$96K
- Viiv Healthcare Company$95K
- AbbVie$7K
- Merck$1K
- Astellas Pharma US Inc$1K
- GSK$1K
- plus $3K from 18 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 196 | $95,888 |
| Viiv Healthcare Company | 203 | $94,679 |
| AbbVie(2 entities) | 64 | $7,242 |
| Merck | 75 | $1,483 |
| Astellas Pharma US Inc | 41 | $1,254 |
| GSK | 13 | $1,162 |
| Insmed, Inc. | 24 | $506 |
| Johnson & Johnson(2 entities) | 26 | $480 |
| Theratechnologies Inc. | 19 | $435 |
| Shionogi Inc | 17 | $417 |
| Janssen Products, LP | 3 | $197 |
| Ferring Pharmaceuticals Inc. | 9 | $189 |
| Paratek Pharmaceuticals, Inc. | 8 | $146 |
| Melinta Therapeutics, LLC | 6 | $111 |
| EMD Serono, Inc. | 5 | $108 |
| Janssen Scientific Affairs, LLC | 3 | $88 |
| Nabriva Therapeutics, PLC | 2 | $77 |
| Napo Pharmaceuticals Inc | 2 | $39 |
| La Jolla Pharmaceutical Company | 1 | $28 |
| Vyera Pharmaceuticals, LLC | 1 | $23 |
| Shire North American Group Inc | 1 | $21 |
| Electromed, Inc. | 1 | $17 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $17 |
| Pfizer | 1 | $12 |
How this compares
$204,618 in reported general payments places this provider in the 90th percentile of 799 infectious disease providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Albany
- Wafaa El SadrNew York$119.1M
- Judith AbergNew York$14.8M
- Stephen ThomasSyracuse$6.2M
- Edward WalshRochester$3.9M
- Magdalena SobieszczykNew York$2.9M
- Kristen MarksNew York$2.8M
- Genovefa PapanicolaouNew York$2.7M
- Catherine SmallValhalla$2.7M
- Ann FalseyRochester$1.7M
- Barry ZingmanBronx$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.